Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 15 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/13/2003 First Published: 8/1/1998


1.		Phase II Study of Dolastatin 10 in Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				VCC-9802 NCI-T98-0007, NCT00005579, T98-0007

Last Modified: 3/1/2000 First Published: 9/1/1998


2.		Phase II Study of Dolastatin 10 in Patients with Unresectable or Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 03/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MDA-DM-98062 NCI-T98-0018, T98-0018

Last Modified: 6/3/2005 First Published: 10/1/1998


3.		Phase II Study of Dolastatin 10 in Patients with Previously Treated Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				NCCTG-983251 NCCTG-98-32-51

Last Modified: 2/22/2008 First Published: 10/1/1998


4.		Phase II Study of Dolastatin 10 in Patients with Locally Advanced, Unresectable, or Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CHNMC-IRB-98039 NCI-T98-0009, T98-0009

Last Modified: 8/1/2000 First Published: 10/1/1998


5.		Phase II Study of Dolastatin 10 in Patients with Hepatobiliary Cancer (Summary Last Modified 08/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				UCCRC-9409 NCI-T98-0010, NCT00003557, T98-0010

Last Modified: 7/1/2000 First Published: 12/1/1998


6.		Phase II Study of Dolastatin 10 in Patients with Hormone Refractory Prostate Cancer (Summary Last Modified 07/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				Not specified				NCI				WSU-D-1644 NCI-T98-0019, NCT00003626, T98-0019

Last Modified: 10/1/1999 First Published: 12/1/1998


7.		Phase II Study of Dolastatin 10 in Patients With Advanced Non-Small Cell Lung Cancer (Summary Last Modified 10/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-98070 NCI-T98-0016, T98-0016

Last Modified: 4/20/2007 First Published: 1/1/1999


8.		Phase II Study of Dolastatin 10 in Patients with Metastatic Pancreatic Adenocarcinoma (Summary Last Modified 08/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				MDA-DM-98071 NCI-T98-0028, NCT00003677, T98-0028

Last Modified: 9/1/2000 First Published: 4/1/1999


9.		Phase II Study of Dolastatin 10 in Patients With Recurrent or Metastatic Soft Tissue Sarcoma (Summary Last Modified 09/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				FCCC-98019 NCI-T98-0026, NCT00003778

Last Modified: 7/16/2004 First Published: 6/1/1999


10.		Phase II Study of Dolastatin 10 in Patients With Recurrent or Metastatic, Platinum Sensitive Ovarian Epithelial Cancer or Primary Peritoneal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				Any age				NCI				GOG-146J

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute